...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>JMIR mHealth and uHealth >Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis
【24h】

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis

机译：使用移动应用程序评级规模（MARS）评估泌尿生殖肿瘤患者的应用：在应用商店和内容分析中系统搜索

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background The large number of available cancer apps and their impact on the population necessitates a transparent, objective, and comprehensive evaluation by app experts, health care professionals, and users. To date, there have been no analyses or classifications of apps for patients with genitourinary cancers, which are among the most prevalent types of cancer. Objective The objective of our study was to analyze the quality of apps for patients diagnosed with genitourinary cancers using the Mobile Application Rating Scale (MARS) and identify high-quality apps. Methods We performed an observational cross-sectional descriptive study of all smartphone apps for patients diagnosed with genitourinary cancers available on iOS and Android platforms. In July 2019, we searched for all available apps for patients with genitourinary cancers (bladder, prostate, cervical, uterine, endometrial, kidney, testicular, and vulvar) or their caregivers. Apps were downloaded and evaluated, and the general characteristics were entered into a database. The evaluation was performed by 2 independent researchers using the MARS questionnaire, which rates 23 evaluation criteria clustered in 5 domains (Engagement, Functionality, Esthetics, Information, and Subjective Quality) on a scale from 1 to 5. Results In total, 46 apps were analyzed. Of these, 31 (67%) were available on Android, 6 (13%) on iOS, and 9 (20%) on both platforms. The apps were free in 89% of cases (41/46), and 61% (28/46) had been updated in the previous year. The apps were intended for prostate cancer in 30% of cases (14/46) and cervical cancer in 17% (8/46). The apps were mainly informative (63%, 29/46), preventive (24%, 11/46), and diagnostic (13%, 6/46). Only 7/46 apps (15%) were developed by health care organizations. The mean MARS score for the overall quality of the 46 apps was 2.98 (SD 0.77), with a maximum of 4.63 and a minimum of 1.95. Functionality scores were quite similar for most of the apps, with the greatest differences in Engagement and Esthetics, which showed acceptable scores in one-third of the apps. The 5 apps with the highest MARS score were the following: “Bladder cancer manager,” “Kidney cancer manager,” “My prostate cancer manager,” “Target Ovarian Cancer Symptoms Diary,” and “My Cancer Coach.” We observed statistically significant differences in the MARS score between the operating systems and the developer types ( P .001 and P =.01, respectively), but not for cost ( P =.62). Conclusions MARS is a helpful methodology to decide which apps can be prescribed to patients and to identify which features should be addressed to improve these tools. Most of the apps designed for patients with genitourinary cancers only try to provide data about the disease, without coherent interactivity. The participation of health professionals in the development of these apps is low; nevertheless, we observed that both the participation of health professionals and regular updates were correlated with quality.
机译：背景技术大量可用的癌症应用程序及其对人口的影响需要通过应用专家，医疗专业人员和用户进行透明，目标和全面的评估。迄今为止，对泌尿病患者没有分析或分类，这是最普遍的癌症类型。目的，我们的研究目的是分析使用移动应用评定规模（MARS）被诊断患有泌尿生殖癌症的患者的应用的质量，并确定高质量的应用。方法对诊断为IOS和Android平台可用的患者进行患者的患者进行了对所有智能手机应用的观察横截面描述性研究。 2019年7月，我们搜索了患有泌尿病患者（膀胱，前列腺，宫颈癌，子宫，子宫内膜，肾，睾丸和外阴）或其护理人员的所有可用应用。下载和评估应用程序，将一般特征输入数据库。评估由2名独立研究人员使用MARS问卷进行，其中23个评估标准在5个域名（参与，功能，美学，信息和主观质量），从1到5中的规模集群。结果总共有46个应用程序分析。其中31个（67％）可在Android，6（13％）的IOS上，以及两个平台上的9（20％）。该应用程序有89％的案件（41/46）免费，61％（28/46）在上一年已更新。该应用程序适用于30％的案件（14/46）和宫颈癌的前列腺癌，17％（8/46）。该应用主要是信息（63％，29/46），预防性（24％，11/46）和诊断（13％，6/46）。由医疗保健组织开发了7/46应用程序（15％）。 46个应用的整体质量的平均MARS评分为2.98（SD 0.77），最大为4.63，最低为1.95。对于大多数应用程序而言，功能分数非常相似，具有最大的参与和美学差异，这在三分之一的应用中显示了可接受的分数。火星分数最高的5个应用程序如下：“膀胱癌症经理”“肾癌经理”，“我的前列腺癌症经理”，“靶卵巢癌症症状日记”，“我的癌症教练”。我们观察了操作系统和开发人员类型之间的MARS评分的统计显着差异（分别为P <.001和P = .01），但不是成本（p = .62）。结论火星是一个有用的方法，可以决定哪些应用程序可以向患者开放，并确定应该解决哪些功能以改善这些工具。为患有泌尿病患者设计的大多数应用程序仅尝试提供有关疾病的数据，而无需相干的相互作用。卫生专业人员在开发这些应用程序的情况下很低;尽管如此，我们观察到卫生专业人士和定期更新的参与都与质量相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号